Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Esperion Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 124 | 1 | 123 | 0 |
| Shares | 74.4M | 100 | 77.3M | +2.90M (+3.9%) |
| Value | $103.6M | $139 | $75.9M | −$27.7M (−26.7%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parallel Advisors, LLC | 478,000 | $468.4K | 0.02% |
| AQR Capital Management LLC | 202,985 | $198.9K | 0.00% |
| Virtu Financial LLC | 181,597 | $178.0K | 0.02% |
| Graham Capital Management, L.P. | 157,747 | $154.6K | 0.00% |
| Acadian Asset Management LLC | 136,346 | $131.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 112,802 | $110.5K | 0.00% |
| Jacob Asset Management of New York LLC | 60,000 | $58.8K | 0.08% |
| Charles Schwab Investment Management Inc | 57,991 | $56.8K | 0.00% |
| Two Sigma Securities, LLC | 36,678 | $35.9K | 0.00% |
| Prudential Financial Inc | 33,260 | $32.6K | 0.00% |
| Sawtooth Solutions, LLC | 30,502 | $29.9K | 0.00% |
| Bleakley Financial Group, LLC | 30,502 | $29.9K | 0.00% |
| Squarepoint Ops LLC | 27,969 | $27.4K | 0.00% |
| Chicago Partners Investment Group LLC | 29,499 | $23.5K | 0.00% |
| Bayesian Capital Management, LP | 17,600 | $17.2K | 0.00% |
| GTS Securities LLC | 14,127 | $13.8K | 0.00% |
| Warberg Asset Management LLC | 13,000 | $12.8K | 0.00% |
| Summit Financial, LLC | 11,887 | $11.6K | 0.00% |
| WT Wealth Management | 10,100 | $9.90K | 0.00% |
| DHJJ Financial Advisors, Ltd. | 1,500 | $1.47K | 0.00% |
| Creative Planning | 100 | $98 | 0.00% |
Sold out (21)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Armistice Capital, LLC | 9,193,000 | $12.8M |
| Braidwell LP | 895,949 | $1.25M |
| Public Employees Retirement System of Ohio | 252,516 | $351.0K |
| Pentwater Capital Management LP | 181,290 | $252.0K |
| UBS Asset Management Americas Inc | 111,482 | $177.3K |
| Y-Intercept (Hong Kong) Ltd | 109,072 | $151.6K |
| Ergoteles LLC | 58,600 | $81.5K |
| Old Mission Capital LLC | 52,029 | $72.3K |
| Allspring Global Investments Holdings, LLC | 42,802 | $59.5K |
| Susquehanna Fundamental Investments, LLC | 41,809 | $58.1K |
| Laurion Capital Management LP | 35,146 | $48.9K |
| BlueCrest Capital Management Ltd | 25,426 | $35.3K |
| Balyasny Asset Management LLC | 16,039 | $22.3K |
| Neuberger Berman Group LLC | 15,899 | $22.1K |
| LMR Partners LLP | 12,400 | $17.2K |
| Captrust Financial Advisors | 10,102 | $14.0K |
| O'Dell Group, LLC | 4,500 | $6.25K |
| Headlands Technologies LLC | 2,110 | $2.93K |
| Northwestern Mutual Wealth Management Co | 1,000 | $1.39K |
| New York State Common Retirement Fund | 628 | $873 |
| IFP Advisors, Inc | 44 | – |
Not filed for Q3 2023 yet (1)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Kistler-Tiffany Companies, LLC | 100 | $139 |